6541
vs
E
EPE
6541
Over the past 12 months, Tanvex BioPharma Inc has outperformed EPE, delivering a return of -23% compared to the EPE's 0% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
6541
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Tanvex BioPharma Inc
TWSE:6541
|
51.6
TWD
|
|||||
|
E
|
Epizyme Inc
F:EPE
|
559
EUR
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
6541, EPE
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Tanvex BioPharma Inc
Revenue
|
|||||||||||
|
E
|
Epizyme Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
6541, EPE
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Tanvex BioPharma Inc
TWSE:6541
|
|||||||||
|
E
|
Epizyme Inc
F:EPE
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Tanvex BioPharma Inc | ||||
|
E
|
Epizyme Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Tanvex BioPharma Inc | ||||
|
E
|
Epizyme Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Tanvex BioPharma Inc | ||||
|
E
|
Epizyme Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Tanvex BioPharma Inc | ||||
|
E
|
Epizyme Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Tanvex BioPharma Inc | ||||
|
E
|
Epizyme Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Tanvex BioPharma Inc | ||||
|
E
|
Epizyme Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Tanvex BioPharma Inc | ||||
|
E
|
Epizyme Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Tanvex BioPharma Inc | ||||
|
E
|
Epizyme Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
6541, EPE
Performance Gap
6541, EPE
Performance By Year
6541, EPE
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
